AU (Australia) Medical Overseas

Medical Overseas Related Terms:
Medical Overseas In AU Australia, AU Offshore Medical, AU Plastic Surgery, AU Suregry Overseas, AU Body Procedures, AU Breast Procedures, AU Cosmetic Surgery, AU Face Procedures, AU Health Tourism, AU Health Travel, AU Healthcare Abroad, AU Medical Outsourcing, AU Medical Tourism, AU Medical Travel, AU Medical Value Travel, AU Offshore Medical, AU Skin Procedures, AU Surgeon, AU Surgery Overseas

Medical Overseas in AU section, includes general infrmation about Medical Overseas Procedure, Medical Overseas AU Local News, Medical Overseas AU Surgeon Locator and other Medical Overseas related material.

Medical Overseas Procedure

Rising health care costs push people to seek medical treatments elsewhere, while medical facilities in developing countries have not only caught up to western standards but also in many ways exceeded them. Health care costs have skyrocketed, something of which anybody contemplating medical treatment is acutely aware. For most people needing medical care, the last thing on their minds is travel. Medical Overseas tourists are usually surprised to find brand new facilities and equipment as hospitals and medical tourism around the world join in the fierce competition for this fast growing market.

"Medical Tourism", or "Medical Overseas" the name for the new practice of going overseas to receive medical treatment and perhaps get a bit of travel in on the side, is becoming a very popular option for many. Medical Overseas tourists travel to places like India, Thailand, Panama, and Argentina, for example. These countries have strongly emerging economies, and have correspondingly made significant investment in their medical capabilities. That translates to quality care at reasonable cost. Diagnostics and tests are done in the same facility, the prognosis and treatment follow immediately. Billing is easy too. It is just a matter of presenting a credit card for the final bill, often determined by an up-front quote.

Price is the major factor that first leads patients to look for Medical Overseas for health care. There are a number of other benefits that often escape notice, although, the price remains the prime motivator for most people. Medical Overseas has its downfalls, and the Medical Overseas tourists should be familiar with possible problems and have an idea what is right for them before planning the details of a trip.

Price is the main reason most people initially cite for their decision to go Medical overseas. Foreign hospitals are far more willing to provide upfront prices. This is excellent for planning purposes and comparing options. Those looking in to Medical Overseas can expect more honesty up-front and fewer hidden costs than those considering a US hospital.

The doctors you will see were very likely trained in the US at some point in their careers, or they have worked in the US, or they are participating very actively in the international medical community. The doctors are quite competent and they are up on the latest medical technologies and treatment. In some cases, they are even leading their respective fields.

Medical Overseas tourism is often as much about the tourism as the medicine. For those undergoing major surgery, there is no better place to recover than a bungalow with a view of the beach while recovering. Similarly, for family accompanying a patient, a week at the beach or a shopping spree can clear up a lot of stress following a surgery.

Is Medical Overseas right for you? If you are not insured and the cost of a medical procedure is looming over your head, or if your insurance will not cover a procedure you need or want because it is classified as an `elective` procedure, you are a prime candidate for investigating treatment overseas.

Other Medical Overseas Procedures
All Other Procedures
Medical Overseas AU (current)
AU Medical tourism
AU Plastic Surgery
AU Plastic Surgeon
AU Cosmetic Surgery

Planing on having medical overseas procedure in AU?
Here is some General Information about AU:

Australia History

The continent of Australia was apparently first settled more than 40,000 years ago with successive waves of immigration of Aboriginal peoples from south and south-east Asia. With rising sea levels after the last Ice Age, Australia became largely isolated from the rest of the world and the Aboriginal tribes developed a variety of cultures, based on a close (spiritual) relationship with the land and nature, and extended kinship. Australian aborigines maintained a hunter/gatherer culture for thousands of years in association with a complex artistic and cultural life - including a very rich 'story-telling' tradition. While the 'modern impression' of Australian Aborigines is largely built around an image of the 'desert people' who have adapted to some of the harshest conditions on the planet (equivalent to the bushmen of the Kalahari), Australia provided a 'comfortable living' for the bulk of aborigines amongst the bountiful flora and fauna on the Australian coast - until the arrival of Europeans.

(WikiT)...

AU medical overseas - Tip of the day:
Risks involved in medical overseas
Patients traveling to AU(Australia) should be aware that local laws involving medical malpractice are not always helpful in claiming compensation. Patients traveling on an offshore medical vacation should check if insurance companies in their home land will compensate for treatment done in AU(Australia).

AU medical overseas - News update:

Context No antidiabetic regimen has demonstrated the ability to reduce progression of coronary atherosclerosis. Commonly used oral glucose-lowering agents include sulfonylureas, which are insulin secretagogues, and thiazolidinediones, which are insulin sensitizers.

Objective To compare the effects of an insulin sensitizer, pioglitazone, with an insulin secretagogue, glimepiride, on the progression of coronary atherosclerosis in patients with type 2 diabetes.

Design, Setting, and Participants Double-blind, randomized, multicenter trial at 97 academic and community hospitals in North and South America (enrollment August 2003-March 2006) in 543 patients with coronary disease and type 2 diabetes.

Interventions A total of 543 patients underwent coronary intravascular ultrasonography and were randomized to receive glimepiride, 1 to 4 mg, or pioglitazone, 15 to 45 mg, for 18 months with titration to maximum dosage, if tolerated. Atherosclerosis progression was measured by repeat intravascular ultrasonography examination in 360 patients at study completion.

Main Outcome Measure Change in percent atheroma volume (PAV) from baseline to study completion.

Results Least squares mean PAV increased 0.73% (95% CI, 0.33% to 1.12%) with glimepiride and decreased 0.16% (95% CI, –0.57% to 0.25%) with pioglitazone(P = .002). An alternative analysis imputing values for noncompleters based on baseline characteristics showed an increase in PAV of 0.64% (95% CI, 0.23% to 1.05%) for glimepiride and a decrease of 0.06% (–0.47% to 0.35%) for pioglitazone (between-group P = .02). Mean (SD) baseline HbA_1c levels were 7.4% (1.0%) in both groups and declined during treatment an average 0.55% (95% CI, –0.68% to –0.42%) with pioglitazone and 0.36% (95% CI, –0.48% to –0.24%) with glimepiride (between-group P = .03). In the pioglitazone group, compared with glimepiride, high-density lipoprotein levels increased 5.7 mg/dL (95% CI, 4.4 to 7.0 mg/dL; 16.0%) vs 0.9 mg/dL (95% CI, –0.3 to 2.1 mg/dL; 4.1%), and median triglyceride levels decreased 16.3 mg/dL (95% CI, –27.7 to –11.0 mg/dL; 15.3%) vs an increase of 3.3 mg/dL (95% CI, –10.7 to 11.7 mg/dL; 0.6%) (P < .001 for both comparisons). Median fasting insulin levels decreased with pioglitazone and increased with glimepiride (P < .001). Hypoglycemia was more common in the glimepiride group and edema, fractures, and decreased hemoglobin levels occurred more frequently in the pioglitazone group.

Conclusion In patients with type 2 diabetes and coronary artery disease, treatment with pioglitazone resulted in a significantly lower rate of progression of coronary atherosclerosis compared with glimepiride.

Trial Registration clinicaltrials.gov Identifier: NCT00225277

Published online March 31, 2008 (doi:10.1001/jama.299.13.1561).

More...